Related Experiment Video
Updated: Sep 29, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Demographics and ocular findings in children with myasthenia
Natalia Arruti1, Pinki Munot2, Richard Bowman3,4
1Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London, WC1N 3JH, UK. n.arruti@nhs.net.
Insights
Juvenile myasthenia gravis (JMG) and congenital myasthenic syndrome (CMS) are key pediatric neuromuscular disorders. Ocular symptoms like ptosis are common, but most children improve with treatment.
Area of Science:
- Neurology
- Ophthalmology
- Pediatrics
Background:
- Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junctions.
- Pediatric MG encompasses juvenile myasthenia gravis (JMG) and congenital myasthenic syndrome (CMS).
- Understanding the demographics and clinical features of pediatric MG is crucial for diagnosis and management.
Purpose of the Study:
- To characterize the demographics of pediatric myasthenia gravis patients.
- To identify the ocular features and common presentations of myasthenia gravis in children.
- To analyze treatment outcomes in pediatric MG.
Main Methods:
- Retrospective chart review of pediatric patients diagnosed with myasthenia gravis.
- Inclusion criteria: patients under 18 years old seen at Great Ormond Street Hospital from 2016-2020.
- Data collected included demographics, clinical presentation, diagnostic findings, and treatment response.
Main Results:
- 49 children were analyzed, with a female predominance.
- Juvenile myasthenia gravis (JMG) was more common than congenital myasthenic syndrome (CMS).
- Ocular involvement, particularly ptosis, was frequent (49%), especially in JMG (70.4%).
- Pyridostigmine was the primary treatment, with 73.5% of patients showing improvement.
Conclusions:
- Juvenile myasthenia gravis (JMG) is the predominant form of pediatric MG.
- Ocular manifestations, including ptosis, are significant presenting signs in pediatric MG.
- Medical management, particularly with pyridostigmine, leads to favorable outcomes in the majority of pediatric MG patients.
Purpose:
To report the demographics and ocular features of myasthenia gravis in the paediatric population.
Methods:
Retrospective revision of the medical records of all patients younger than 18 years of age with myasthenia who were examined at Great Ormond Street Hospital between the 1st of January 2016 and 1st of January 2020.
Results:
A total of 49 children were assessed during the 4-year period. There was a female predominance, with only 12 males (24.5%). 26 children (53.1%) had juvenile myasthenia gravis (JMG) while 18 (36.7%) had congenital myasthenic syndrome (CMS). 4 patients (8.2%) were diagnosed with probable CMS while 1 (2.0%) was classified as probable JMG. The mean age at diagnosis was 5.3 years old (SD 3.9) whereas the mean age at onset was 3.7 years old (SD 3.9). Almost half of the children (49%) had ocular involvement, present in 19 patients in the JMG group (70.4%) and in 5 children (22.7%) in the CMS cohort. Ptosis was the most common sign at presentation, seen in 32 patients (65.3%). Nine patients (18.4%) presented with a squint and another 7 (14.3%) developed it later on. Anti-acetylcholine receptor antibodies were positive in 18 of the 26 JMG patients (69.2%) whereas identifiable mutations were found in the 18 CMS patients (100%). Pyridostigmine was the drug of choice in our series, used by thirty-three patients (67.3%). The majority of the patients (73.5%) improved after treatment.
Conclusions:
JMG was the most common type of paediatric MG, specifically the ocular form. Ptosis was the most common sign at presentation. The majority of the patients improved after medical treatment.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Accessory Structures of the Eye
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...

